Actuate Therapeutics Stock (NASDAQ: ACTU) stock price, news, charts, stock research, profile.
Open | $6.94 |
Close | $6.52 |
Volume / Avg. | 24.66K / 42.99K |
Day Range | $6.51 - $6.99 |
52 Wk Range | 6.05 - 10.16 |
Market Cap | $155.95M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 26 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Actuate Therapeutics (NASDAQ:ACTU) through any online brokerage.
Other companies in Actuate Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Adverum Biotechnologies (NASDAQ:ADVM), Citius Oncology (NASDAQ:CTOR), Adicet Bio (NASDAQ:ACET) and Agenus (NASDAQ:AGEN).
There is no analysis for Actuate Therapeutics to provide a consensus price target.
The stock price for Actuate Therapeutics (NASDAQ: ACTU) is $6.51 last updated September 24, 2024 at 3:50 PM EDT.
There are no upcoming dividends for Actuate Therapeutics.
Actuate Therapeutics’s Q3 earnings are confirmed for Thursday, November 21, 2024.
There is no upcoming split for Actuate Therapeutics.
Actuate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.